title: Contrasting effects of excitotoxic lesions of the prefrontal cortex on the behavioural response to D-amphetamine and presynaptic and postsynaptic measures of striatal dopamine function in monkeys.
abstract: The effects of excitotoxic lesions of the prefrontal cortex on behavioural, neurochemical and molecular indices of dopamine function in the caudate nucleus were studied in the marmoset. The lesion, which encompassed both the lateral and orbital regions of prefrontal cortex, made the animals more sensitive to the performance disrupting effects of the dopamine releasing drug, D-amphetamine, in a variation of the object retrieval task. Specifically, following drug administration, the lesioned marmosets were less able to gain access to food reward in the minimum number of responses. Analysis of the nature of the errors suggested that the deficit was not due to inhibition of a prepotent response as the lesioned monkeys were just as likely to make a detour reach to the unopened side of the box as a direct "line-of-sight" reach into the unopened front of the box. Rather, the data indicated a general disorganization of behaviour. The enhanced behavioural responsiveness to manipulations increasing presynaptic dopamine function was accompanied by neurochemical changes indicating a reduced responsiveness, as revealed by in vivo microdialysis. Thus, in lesioned animals, whilst there were no effects on baseline levels of extracellular dopamine in dorsolateral caudate, evoked release, both to systemic D-amphetamine and to a local depolarizing pulse of potassium ions, was attenuated. These opposite effects of the prefrontal cortex lesion on behavioural and neurochemical indices of striatal dopamine function occurred in the absence of any changes in striatal dopamine receptors of the D1 and D2 subtype, as determined both by radioligand binding assays and measurements of messenger RNA using in situ hydridization techniques. These data provide further insight into the interactions between prefrontal cortex and striatal dopamine function in the non-human primate. In particular, when taken in the light of our previous studies they indicate that following prefrontal manipulations, concurrence between behavioural and neurochemical indices of striatal dopamine function depends, critically, on the behavioural task. These findings are discussed with respect to the growing body of evidence implicating abnormalities in frontostriatal neurotransmission in complex disorders such as schizophrenia.
authors.affiliation: The Babraham Institute, Department of Neurobiology, Cambridge, U.K.
authors.forename: L S
authors.initials: LS
authors.lastname: Wilkinson
authors.forename: R
authors.initials: R
authors.lastname: Dias
authors.forename: K L
authors.initials: KL
authors.lastname: Thomas
authors.forename: S J
authors.initials: SJ
authors.lastname: Augood
authors.forename: B J
authors.initials: BJ
authors.lastname: Everitt
authors.forename: T W
authors.initials: TW
authors.lastname: Robbins
authors.forename: A C
authors.initials: AC
authors.lastname: Roberts
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001552:Benzazepines / Q000378:metabolism; D001931:Brain Mapping; D002144:Callithrix; D002421:Caudate Nucleus / Q000187:drug effects / Q000502:physiology*; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology*; D003913:Dextroamphetamine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D007858:Learning / Q000187:drug effects / Q000502:physiology*; D017551:Microdialysis; D009498:Neurotoxins; D015345:Oligonucleotide Probes; D011188:Potassium / Q000494:pharmacology; D017397:Prefrontal Cortex / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology*; D011699:Putamen / Q000187:drug effects / Q000502:physiology; D017378:Quinolinic Acid; D011869:Radioligand Assay; D017447:Receptors, Dopamine D1 / Q000096:biosynthesis / Q000502:physiology; D017448:Receptors, Dopamine D2 / Q000096:biosynthesis / Q000502:physiology; D013134:Spiperone / Q000378:metabolism; D013569:Synapses / Q000187:drug effects / Q000502:physiology*
chemical_list: D001552:Benzazepines; D009498:Neurotoxins; D015345:Oligonucleotide Probes; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D013134:Spiperone; D017378:Quinolinic Acid; D011188:Potassium; D003913:Dextroamphetamine; D004298:Dopamine